Predictors of Node Positivity in Endometrial Cancer
NCT05793333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-09-19
Summary
To investigate the role of histological and moleculr profile of endometrial cancer patietns in predicting the risk of nodal metastases in endometrila cancer patients.
Conditions
Sponsors & Collaborators
-
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
lead OTHER
Principal Investigators
-
Giorgio Bogani, MD · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-10
- Primary Completion
- 2024-12-31
- Completion
- 2025-01-01
Countries
- Italy
Study Locations
More Related Trials
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT06584630 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Markers in Treatment in Endometrial Cancer
NCT00598845 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer.
NCT06279832 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors
NCT05168631 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
NCT06656949 ·Status: RECRUITING ·Phase: NA
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 ·Status: UNKNOWN
-
Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
NCT06250010 ·Status: RECRUITING
-
The Prognostic Value of Serum Biomarkers in Osteosarcoma
NCT05093101 ·Status: COMPLETED
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial
NCT06900582 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Implementing Precision Medicine in cOmmunity HospiTALs
NCT05283044 ·Status: RECRUITING ·Phase: NA
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Studies of Neurological Paraneoplastic Syndromes
NCT00587106 ·Status: COMPLETED
-
Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
NCT02586844 ·Status: COMPLETED
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NCT06800469 ·Status: RECRUITING ·Phase: NA
-
Biomolecular Analysis for Predicting Response to Regorafenib
NCT05759195 ·Status: COMPLETED ·Phase: NA
-
MSI in Circulatory DNA of Endometrial Cancer
NCT03744962 ·Status: UNKNOWN
-
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique
NCT03766672 ·Status: COMPLETED